Folic Acid Supplementation: When to Start? How Long to Continue?
Folic acid supplementation before and during early pregnancy substantially reduces the risk of neural tube defects. Emerging research suggests that folic acid may have beneficial effects on neurodevelopment that extend beyond the first trimester. We review the evidence on the timing of folic acid supplementation and findings from the FASSTT randomized controlled trial, which examined whether supplementation during the second and third trimesters was associated with improved cognitive outcomes in children.
Essential Reads: Why All Women of Reproductive Age Should Take Folic Acid
Folic Acid Awareness Week (Sept 13-19, 2026) focuses on the importance of daily folic acid supplements for women to prevent birth defects, as diet alone is often insufficient.
Quetiapine Use During Pregnancy: What Do We Know About Reproductive Safety?
For women who require treatment with quetiapine during pregnancy, the available reproductive safety data are generally reassuring. The largest body of evidence does not suggest a meaningful increase in major congenital malformations, while metabolic effects, particularly gestational diabetes, remain an important consideration.
September is Suicide Prevention Awareness Month: Emergency Resources for Individuals with Perinatal Mental Health Issues
If you or someone you know is in crisis, confidential support is available.
Weekly Roundup for September 4, 2026: Recent Publications in Women’s Mental Health
Suicide risk during pregnancy and the postpartum, use of modafinil in pregnancy, and new treatment for menopausal symptoms are featured in this week’s roundup.
Atomoxetine and Stimulants During Pregnancy: What Do We Know About Pregnancy Outcomes?
A new study examines pregnancy outcomes among women using stimulants or atomoxetine during pregnancy, finding modest increases in some complications with stimulant use while highlighting important limitations of observational data.